Goldman Sachs’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History

Goldman Sachs's LRND Position: Q2 2026 in Review

Goldman Sachs reduced its New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) stake by 32% in Q2 2026, selling an estimated $95.5K and leaving 4,700 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #6184.

Goldman Sachs first reported a position in LRND in Q1 2026 and has held it in 2 quarters since. The position peaked at $257K in Q1 2026. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.

• Goldman Sachs held 4,700 shares of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF worth $207K as of Q2 2026.
• Goldman Sachs sold 2,225 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $95.5K.
• New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6184 holding.
• Goldman Sachs first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q1 2026 and has held it in 2 quarters since.
• Goldman Sachs's New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position peaked at $257K in Q1 2026.
• 6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.